Portfolio company
Helix Nanotechnologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech company develops an mRNA platform to create vaccines and therapies for biotechnology organisations and patients with complex immune requirements.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
HelixNano
This biotechnology company develops messenger RNA technologies and vaccines for patients with infectious diseases, cancer, and organ transplant needs.
ParcelBio
This deep-tech firm develops mRNA delivery technologies and programmable medicines for biotechnology and pharmaceutical organisations to treat autoimmune diseases and oncology.
Rewrite Therapeutics
This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.
EditForce
This deep-tech firm develops RNA editing tools and therapies for pharmaceutical, industrial, and agricultural organisations to treat diseases and manipulate genes.
Sensible Biotechnologies
This company develops a cell-based platform to produce mRNA for pharmaceutical firms and biotechnology researchers developing therapeutics and vaccines.
Kerna
This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.
GC Therapeutics
This deep-tech company develops a cell programming platform to produce off-the-shelf medicines for patients with gastrointestinal, neurological and immunological diseases.
Catena Biosciences
This deep-tech company develops protein conjugation technology and multi-payload conjugates to create targeted therapeutics for patients with oncology and autoimmune diseases.
